Navigation Links
A Fish a Day to Keep the Pain Away?
Date:10/22/2013

Sturgeon Bay, WI (PRWEB) October 22, 2013

Many patients consult Sturgeon Bay, Wisconsin Chiropractor and Naturopath Dr. J G Moellendorf, DC, ND, LCP looking for non-drug and non-surgical solutions to relieve their chronic pain. Often they are looking for natural alternatives because of adverse reactions and side-effects to their pain medications.

The August 31, 2013 issue of The Lancet published Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. The authors did meta-analyses of 280 trials comparing non-steroidal anti-inflammatory drugs (NSAIDs) to placebos involving 124,513 participants. They also looked at 474 trials comparing one NSAID to another involving 229,296 participants. Major vascular events (heart attacks, strokes, etc.) were increased by nearly a third by those using a coxib or diclofenac. While ibuprofen significantly increased major coronary events, it did not significantly increase vascular events. The risk of heart failure was roughly doubled along with increased upper gastrointestinal complications by all NSAIDs studied.

The research team led by Ru-Rong Ji at Duke University Medical Center examined the bioactive lipid neuroprotectin D1/protectin D1 (NPD1/PD1) which is produced in human white blood cells in response to external stimuli such as stress or pain. NPD1/PD1 has been found to resolve both brain and abdominal inflammation and the resulting pain. Their results were published in the Annals of Neurology May 2013 titled Neuroprotectin/protectin D1 protects against neuropathic pain in mice after nerve trauma. While NPD1/PD1 is derived from omega-3 fatty acids found in the oil of cold water fish, it is 1000 times more powerful at reducing inflammation than omega-3 fatty acids. The researchers found that not only did NPD1/PD1 relieve pain, it reduced nerve swelling and protected the nerves from further damage following injuries.

Earlier research about the benefits of omega-3 fatty acids as a natural alternative for controlling pain was done by Dr. Joseph Maroon, MD, professor of neurosurgery at the University of Pittsburgh Medical School. Dr. Maroon specializes in treating chronic degenerative spine disease. He is also the team neurosurgeon for the Pittsburgh Steelers football team. Dr. Maroon has had outstanding success treating both chronic pain patients and injured football players with high doses of omega-3 fatty acids from fish oil.

Dr. Maroon reported his amazing results at the 73rd meeting of the American Association of Neurological Surgeons. He treated 253 non-surgical candidates with chronic neck or back pain with high daily doses of omega-3 fatty acids. After an average of 75 days, 59% had stopped taking their prescription pain killers, and 88% were pleased enough with their results that they continued taking the omega-3 supplements. No significant adverse effects were reported in his study. Dr. Moellendorf notes that this study, along with many parallel research studies, have found that omega-3 fatty acids are equal to ibuprofen in the reduction of arthritic pain.

Quoting Dr. J G Moellendorf, DC, ND, LCP, "When they’re in pain, patients demand fast relief. Unfortunately, they often aren’t aware of the damaging side effects of their pain relief medications. While eating cold water fish alone is probably not enough, the current research points to the benefits of high doses of omega-3 fatty acids, and now the use of NPD1/PD1 from fish oil in controlling pain. Though these alternatives may not work as quickly, they offer fewer adverse reactions."

Using the latest research findings, Moellendorf Chiropractic Office, Ltd. uses a comprehensive package of Chiropractic care, decompression traction therapy, active therapeutic movement training, cold laser therapy, and nutrition for the natural treatment of neurological conditions, neck and back pain, and other health conditions without drugs or surgery. Additional information about Chiropractic, Naturopathy, and other forms of natural health care has been provided by Moellendorf Chiropractic Office, Ltd. at http://www.all-about-wellness.com.

About: Dr. J G Moellendorf, DC, ND, LCP

Dr. J G Moellendorf, DC, ND, LCP attended the University of Wisconsin—Superior where he majored in Physics and Mathematics, with a minor in art photography. While attending the University of Minnesota—Minneapolis, he assisted in research on ribosomal proteins. Completing his Chiropractic studies at Palmer College of Chiropractic in Davenport, Iowa, he graduated Cum Laude (with high honors) in 1983. He started Moellendorf Chiropractic Office, Ltd. in Sturgeon Bay, Wisconsin in 1983. In 1996, Dr. Moellendorf was awarded his Doctorate in Naturopathy from Trinity School of Natural Health. In 2001, he received Chiropractic’s most prestigious award, the honorary Legion of Chiropractic Philosophers degree, for his thesis "The Workings of Innate Intelligence in Obsessive/Compulsive and Addictive Behaviors." This paper was chosen for publishing in the book Philosophic Contemplations vol. 2 in 2002. In June of 2012, Dr. Moellendorf authored his first book titled Healthcare’s Best Kept Secret which can be ordered on Amazon. Dr. Moellendorf can be contacted by phone (920) 493-2126, fax (920) 743-1145, email jgmoellendorf(at)itol(dot)com, his website at http://www.all-about-wellness.com, or send a carrier pigeon to 44.84722N and 87.36416W.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11249744.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... World Technology Awards. uBiome is one of just six company finalists in the ... In addition to uBiome, companies nominated as finalists in this year’s awards include ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016 Soligenix, ... biopharmaceutical company focused on developing and commercializing products to ... need, announced today that it will be hosting an ... am ET on the origins of innate defense regulators ... a review of oral mucositis and the recently announced ...
(Date:12/8/2016)... Eutilex Co. Ltd. today announced that it ... A financing. This financing round included participation from DS ... Bio Angel. This new funding brings the total capital ... since its founding in 2015. The ... commercialization of its immuno-oncology programs, expand its R&D capabilities ...
(Date:12/7/2016)... San Diego (PRWEB) , ... December 07, 2016 ... ... safety data from its phase I/II dose escalation and expansion clinical trial for ... 2016 in Vienna, Austria. The purpose of the trial was to determine the ...
Breaking Biology Technology:
(Date:11/22/2016)... Nov. 22, 2016   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... Healthcare and Life Sciences Awards as "Most Outstanding ... an unprecedented year of recognition and growth for MedNet, ... 15 years. iMedNet ™ , ...
(Date:11/16/2016)... Nov. 16, 2016 Sensory Inc ., ... security for consumer electronics, and VeriTran , ... retail industry, today announced a global partnership that ... to authenticate users of mobile banking and mobile ... software which requires no specialized biometric scanners, ...
(Date:6/27/2016)... Research and Markets has announced the addition ... to their offering. The report ... to grow at a CAGR of 12.28% during the period 2016-2020. ... in-depth market analysis with inputs from industry experts. The report covers ... The report also includes a discussion of the key vendors operating ...
Breaking Biology News(10 mins):